Kiora Pharmaceuticals, Inc. ( KPRX) - Key Metrics
KPRX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | -$1.56 | -$0.52 | -$0.54 |
| 2025Q3 | ? | $0.01 | -$0.30 | -$0.30 |
| 2025Q2 | ? | -$0.54 | -$0.95 | -$0.96 |
| 2025Q1 | ? | -$0.52 | -$0.64 | -$0.64 |
KPRX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -0.31 |
| 2025Q3 | ? | 111.22 |
| 2025Q2 | ? | -1.33 |
| 2025Q1 | ? | -1.45 |
KPRX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -39.30% | ? |
| 2025Q4 | -27.52% | ? |
| 2025Q3 | -10.68% | ? |
| 2025Q2 | -33.39% | ? |
| 2025Q1 | -21.30% | ? |
KPRX
Price: $2.53
52 week price:
Earnings Per Share: -2.64 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 47600
Market Capitalization: 11.7 million